Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$77.7 - $123.62 $411,810 - $655,186
-5,300 Reduced 35.57%
9,600 $1.05 Million
Q2 2024

Aug 14, 2024

SELL
$58.87 - $83.05 $818,293 - $1.15 Million
-13,900 Reduced 48.26%
14,900 $1.2 Million
Q1 2024

May 15, 2024

BUY
$51.07 - $68.26 $459,630 - $614,340
9,000 Added 45.45%
28,800 $1.79 Million
Q4 2023

Feb 14, 2024

SELL
$55.6 - $77.89 $1.53 Million - $2.15 Million
-27,600 Reduced 58.23%
19,800 $1.23 Million
Q3 2023

Nov 14, 2023

BUY
$60.27 - $90.75 $2.4 Million - $3.62 Million
39,900 Added 532.0%
47,400 $3.29 Million
Q2 2023

Aug 14, 2023

SELL
$82.41 - $99.65 $1.98 Million - $2.39 Million
-24,000 Reduced 76.19%
7,500 $629,000
Q1 2023

May 15, 2023

SELL
$47.76 - $82.86 $549,240 - $952,890
-11,500 Reduced 26.74%
31,500 $2.6 Million
Q4 2022

Feb 14, 2023

SELL
$48.76 - $77.67 $1.76 Million - $2.8 Million
-36,100 Reduced 45.64%
43,000 $2.19 Million
Q3 2022

Nov 14, 2022

BUY
$61.42 - $86.29 $4.68 Million - $6.58 Million
76,200 Added 2627.59%
79,100 $5.56 Million
Q2 2022

Aug 08, 2022

BUY
$55.54 - $72.65 $149,958 - $196,155
2,700 Added 1350.0%
2,900 $191,000
Q1 2022

May 16, 2022

BUY
$24.28 - $56.64 $2,428 - $5,664
100 Added 100.0%
200 $11,000
Q4 2021

Feb 14, 2022

SELL
$22.54 - $30.44 $126,224 - $170,464
-5,600 Reduced 98.25%
100 $3,000
Q3 2021

Nov 15, 2021

BUY
$24.23 - $28.59 $58,152 - $68,616
2,400 Added 72.73%
5,700 $146,000
Q1 2021

May 17, 2021

BUY
$13.77 - $21.66 $45,441 - $71,478
3,300 New
3,300 $71,000
Q4 2020

Feb 16, 2021

SELL
$10.75 - $14.91 $9,675 - $13,419
-900 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$11.98 - $16.34 $31,148 - $42,484
-2,600 Reduced 74.29%
900 $11,000
Q1 2020

May 15, 2020

BUY
$9.11 - $20.05 $31,884 - $70,175
3,500 New
3,500 $45,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.22B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.